Intravenous Infusions is trading 10% up at GHS 0.33, extending a multi-session rally following a disclosed stake purchase by CCM Healthcare Investments FZCO.
- The Ghana-listed pharmaceutical producer has climbed steadily since July 7, 2026, after news that CCM acquired over 1 million shares.
- CCM aims to support the company with its healthcare investment expertise, helping sustain strong buying interest despite a weaker global healthcare sector.